ALTU

Altus's Phase III efficacy trial of Trizytek meets primary endpoint - 08/13 - 11:00 AM ET

Altus Pharmaceuticals Closes At New Low - 08/12 - 04:19 PM ET

Altus shares plunge 50% following results for Phase III Trizytek trail - 08/12 - 02:09 PM ET

Shares Of Altus Plunge On Disappointing Cystic Fibrosis Drug Study - 08/12 - 10:22 AM ET

Altus Pharmaceuticals Continues To Fall In Pre-Market - 08/12 - 08:51 AM ET

Altus Pharmaceuticals Drops In After-Hours - 08/11 - 05:07 PM ET

Altus Pharmaceuticals Announces Achievement of Primary Endpoint in Phase 3 Efficacy Trial of Trizytek for Cystic Fibrosis Patients with Pancreatic Insufficiency - 08/11 - 04:05 PM ET

ALTU: Q2 Earnings Call @ 11:00 ET Today [delayed] - 08/05 - 08:24 AM ET

Altus Pharmaceuticals Reports Second Quarter 2008 Results - 08/05 - 08:00 AM ET

Altus Pharmaceuticals to Host Second Quarter Investor Conference Call on August 5, 2008 - 07/24 - 10:19 AM ET

Altus Pharmaceuticals Announces Webcast of Presentation at Collins Stewart Growth Conference - 07/07 - 12:36 PM ET

Altus Pharmaceuticals Inc. (ALTU) Corporate Event Announcement Notice - 06/25 - 08:38 PM ET

ALTU: To Present At Jefferies Healthcare Conference @ 08:30 ET [delayed] - 06/25 - 07:54 AM ET

Altus Pharmaceuticals Inc. (ALTU) Corporate Event Announcement Notice - 06/24 - 08:36 PM ET

ALTU: To Present At Piper Jaffray Europe Conference @ 07:00 ET [delayed] - 06/24 - 07:23 AM ET

Altus Pharmaceuticals to Present at Upcoming Investor Conferences - 06/17 - 10:12 AM ET

Altus reports last patient visit of Phase III cystic fibrosis trial - 06/16 - 12:41 PM ET

Altus Pharmaceuticals Reports Last Patient Visit Of Trizytek(TM) Phase 3 Efficacy Trial - 06/13 - 08:27 AM ET

Altus reports positive results from Phase I hyperoxaluria trial - 06/04 - 12:42 PM ET

ALTU: Positive Top-Line Results in Ph 1 Trial Results of ALTU-237 - 06/03 - 09:03 AM ET

Page 1 of 5     1  2   3   4   5      Previous  |  Next

<< Back to Stock Index